突破性疗法-话题@MedSci

#突破性疗法#

77篇内容 | 1366人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1536181, encodeId=98eb15361813f, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=药明生物祝贺Amicus新一代庞贝氏症疗法获FDA突破性疗法认定, objectType=article, longId=161438, objectId=c9f2161438db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9f2161438db, replyNumber=0, likeNumber=56, createdTime=2019-03-02, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9f2161438db, moduleTitle=药明生物祝贺Amicus新一代庞贝氏症疗法获FDA突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c9f2161438db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536180, encodeId=6984153618058, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=！Amicus庞培病疗法获突破性疗法认定, objectType=article, longId=161370, objectId=38be1613e074, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38be1613e074, replyNumber=0, likeNumber=0, createdTime=2019-03-01, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38be1613e074, moduleTitle=！Amicus庞培病疗法获突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38be1613e074)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536179, encodeId=4a2115361e94c, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=中国第一个获得美国FDA“突破性疗法”认证的抗癌新药到底好在哪？, objectType=article, longId=158826, objectId=ae6c15882697, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae6c15882697, replyNumber=0, likeNumber=53, createdTime=2019-01-26, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae6c15882697, moduleTitle=中国第一个获得美国FDA“突破性疗法”认证的抗癌新药到底好在哪？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae6c15882697)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536178, encodeId=c94a15361e837, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=中国本土研发的抗癌疗法首次获FDA突破性疗法认定, objectType=article, longId=158423, objectId=b1a1158423d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1a1158423d6, replyNumber=0, likeNumber=39, createdTime=2019-01-20, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1a1158423d6, moduleTitle=中国本土研发的抗癌疗法首次获FDA突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1a1158423d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536177, encodeId=1b6e15361e7c1, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=百济神州宣布美国食品药品监督管理局（FDA）授予Zanubrutinib突破性疗法认定用于治疗套细胞淋巴瘤患者, objectType=article, longId=158141, objectId=4f381581410d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f381581410d, replyNumber=0, likeNumber=42, createdTime=2019-01-17, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f381581410d, moduleTitle=百济神州宣布美国食品药品监督管理局（FDA）授予Zanubrutinib突破性疗法认定用于治疗套细胞淋巴瘤患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f381581410d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536176, encodeId=240715361e616, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=FDA认定rucaparib作为前列腺癌突破性疗法资格, objectType=article, longId=150493, objectId=ac7615049308, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac7615049308, replyNumber=0, likeNumber=50, createdTime=2018-10-08, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac7615049308, moduleTitle=FDA认定rucaparib作为前列腺癌突破性疗法资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac7615049308)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536175, encodeId=124315361e5ec, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=阿斯利康哮喘新药tezepelumab获得美国FDA突破性疗法认定, objectType=article, longId=148544, objectId=840b148544ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=840b148544ae, replyNumber=0, likeNumber=39, createdTime=2018-09-11, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=840b148544ae, moduleTitle=阿斯利康哮喘新药tezepelumab获得美国FDA突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=840b148544ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536174, encodeId=c30415361e459, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=FDA授予IgE单抗Xolair突破性疗法认定，治疗食物过敏, objectType=article, longId=146617, objectId=039914661e80, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=039914661e80, replyNumber=0, likeNumber=56, createdTime=2018-08-16, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=039914661e80, moduleTitle=FDA授予IgE单抗Xolair突破性疗法认定，治疗食物过敏, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=039914661e80)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536173, encodeId=aa3315361e35e, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=结节性硬化症突破性疗法：西罗莫司凝胶, objectType=article, longId=136294, objectId=ec0f13629473, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec0f13629473, replyNumber=0, likeNumber=35, createdTime=2018-04-25, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec0f13629473, moduleTitle=结节性硬化症突破性疗法：西罗莫司凝胶, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec0f13629473)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536172, encodeId=14ec15361e2af, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=乌帕替尼获突破性疗法认定, objectType=article, longId=128339, objectId=314a1283390e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=314a1283390e, replyNumber=0, likeNumber=28, createdTime=2018-02-01, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=314a1283390e, moduleTitle=乌帕替尼获突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=314a1283390e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536171, encodeId=368615361e183, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=MSD/Eisai癌症组合获美国突破性疗法认定, objectType=article, longId=126183, objectId=a02312618301, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a02312618301, replyNumber=0, likeNumber=36, createdTime=2018-01-12, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a02312618301, moduleTitle=MSD/Eisai癌症组合获美国突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a02312618301)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536170, encodeId=592415361e0fe, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=治疗大 B 细胞淋巴瘤又一单抗获 FDA 突破性疗法指定, objectType=article, longId=117910, objectId=9e7d11e910f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e7d11e910f4, replyNumber=0, likeNumber=34, createdTime=2017-10-29, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e7d11e910f4, moduleTitle=治疗大 B 细胞淋巴瘤又一单抗获 FDA 突破性疗法指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e7d11e910f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536169, encodeId=4ba21536169b7, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=血友病基因疗法获美国FDA突破性疗法认定, objectType=article, longId=117866, objectId=305c11e866b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=305c11e866b2, replyNumber=0, likeNumber=42, createdTime=2017-10-29, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=305c11e866b2, moduleTitle=血友病基因疗法获美国FDA突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=305c11e866b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536168, encodeId=0b53153616801, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=阿斯利康承认子公司抗癌药临床数据造假，刚获突破性疗法认定, objectType=article, longId=116767, objectId=4036116e673e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4036116e673e, replyNumber=0, likeNumber=35, createdTime=2017-10-20, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4036116e673e, moduleTitle=阿斯利康承认子公司抗癌药临床数据造假，刚获突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4036116e673e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536167, encodeId=336b153616ed0, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=美国将摇头丸指定为突破性疗法, objectType=article, longId=111341, objectId=6a9011134101, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a9011134101, replyNumber=0, likeNumber=33, createdTime=2017-08-31, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a9011134101, moduleTitle=美国将摇头丸指定为突破性疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a9011134101)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536166, encodeId=65a6153616608, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=FDA：白血病新药获FDA突破性疗法认定, objectType=article, longId=99269, objectId=6a66992695b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a66992695b, replyNumber=0, likeNumber=44, createdTime=2017-05-22, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a66992695b, moduleTitle=FDA：白血病新药获FDA突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a66992695b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536165, encodeId=3a271536165f1, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=诺华CAR-T CTL019再获突破性疗法认定, objectType=article, longId=96403, objectId=ca1f96403c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca1f96403c9, replyNumber=0, likeNumber=32, createdTime=2017-04-21, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca1f96403c9, moduleTitle=诺华CAR-T CTL019再获突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca1f96403c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536164, encodeId=70ef15361644f, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=50年来首例！动脉炎新药获FDA突破性疗法认定, objectType=article, longId=79514, objectId=c30be951421, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c30be951421, replyNumber=0, likeNumber=42, createdTime=2016-10-10, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c30be951421, moduleTitle=50年来首例！动脉炎新药获FDA突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c30be951421)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536163, encodeId=ab5a153616330, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=人类的“祖奶奶”是怎么死的？老年痴呆突破性疗法, objectType=article, longId=76715, objectId=a609e6715c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a609e6715c6, replyNumber=0, likeNumber=24, createdTime=2016-09-07, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a609e6715c6, moduleTitle=人类的“祖奶奶”是怎么死的？老年痴呆突破性疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a609e6715c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536162, encodeId=b9871536162bb, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, objectTitle=强生/Genmab联手拿下Darzalex突破性疗法地位进军二线用药市场, objectType=article, longId=73919, objectId=9afae391959, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9afae391959, replyNumber=0, likeNumber=41, createdTime=2016-07-29, rootId=0, userName=zhwj, userId=7eca12667393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9afae391959, moduleTitle=强生/Genmab联手拿下Darzalex突破性疗法地位进军二线用药市场, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9afae391959)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

突破性疗法

2020-05-29

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

药明生物祝贺Amicus新一代庞贝氏症疗法获FDA突破性疗法认定

2019-03-02

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

！Amicus庞培病疗法获突破性疗法认定

2019-03-01

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

中国第一个获得美国FDA“突破性疗法”认证的抗癌新药到底好在哪？

2019-01-26

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

中国本土研发的抗癌疗法首次获FDA突破性疗法认定

2019-01-20

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

百济神州宣布美国食品药品监督管理局（FDA）授予Zanubrutinib突破性疗法认定用于治疗套细胞淋巴瘤患者

2019-01-17

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

FDA认定rucaparib作为前列腺癌突破性疗法资格

2018-10-08

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

阿斯利康哮喘新药tezepelumab获得美国FDA突破性疗法认定

2018-09-11

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

FDA授予IgE单抗Xolair突破性疗法认定，治疗食物过敏

2018-08-16

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

结节性硬化症突破性疗法：西罗莫司凝胶

2018-04-25

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

乌帕替尼获突破性疗法认定

2018-02-01

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

MSD/Eisai癌症组合获美国突破性疗法认定

2018-01-12

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

治疗大 B 细胞淋巴瘤又一单抗获 FDA 突破性疗法指定

2017-10-29

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

血友病基因疗法获美国FDA突破性疗法认定

2017-10-29

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

阿斯利康承认子公司抗癌药临床数据造假，刚获突破性疗法认定

2017-10-20

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

美国将摇头丸指定为突破性疗法

2017-08-31

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

FDA：白血病新药获FDA突破性疗法认定

2017-05-22

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

诺华CAR-T CTL019再获突破性疗法认定

2017-04-21

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

50年来首例！动脉炎新药获FDA突破性疗法认定

2016-10-10

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

人类的“祖奶奶”是怎么死的？老年痴呆突破性疗法

2016-09-07

zhwj (审核中...)

前往app查看评论内容

#突破性疗法#

强生/Genmab联手拿下Darzalex突破性疗法地位进军二线用药市场

2016-07-29

科室
- - 订阅+
  - 更多科室
工具
服务